Lenalidomid Alvogen 20 mg tvrde kapsule
| Name | Lenalidomid Alvogen 20 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-668924151 |
| Active Substance | lenalidomidum |
| Composition | jedna kapsula sadrži 20 mg lenalidomida |
| Pharmaceutical Form | kapsula, tvrda |
| Packaging [MA Number for Packaging] | 21 kapsula u blisteru, u kutiji [HR-H-668924151-01] |
| Manufacturer | Pharmadox Healthcare Limited, Paola PLA, Malta
Pharmacare Premium Ltd., Birzebbugia, Malta S.C Labormed - Pharma SA, Bukurešt, Rumunjska |
| Marketing Authorisation Holder | Alvogen Pharma Trading Europe EOOD, 86A Bulgaria blvd., Sofija, Bugarska |
| Marketing Authorisation Date | 15.07.2020 |
| MA Period of Validity | 30.04.2023 |
| Classification Number | UP/I-530-09/17-01/165 |
| Registration Number | 381-12-01/30-20-17 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L04AX04 |
| Medicinal product marketed in the Croatia | Ne |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Vodic za zdravstvene radnike verzija 4 Obrazac pristanka bolesnika, verzija 3 Obrazac za prijavu trudnoće, verzija 2 |
| Educational materials for patients / caregivers |
Vodic za bolesnike verzija 4 Kartica za bolesnika, verzija 3 |
